bpc 157 local or systemic Regeneration Risk? A Narrative Review of BPC-157 for Musculoskeletal Healing Stable Gastric Pentadecapeptide BPC 157

For research summaries and trial details, see Tonums research hub

recent consensus appears to be moving in this direction (Kuhlmann et al., 2023)

In the case of TB, there is a very strong genetic basis of susceptibility to this bacterium, with resistance developing among the indigenous north American population after European colonization, owing to the high initial mortality and therefore rapid selection against susceptibility genes (Abel et al., 2018)

Note that most BPC-157 research so far has been conducted in animals, so its benefits aren't yet established in humans, though anecdotal user reports are encouraging

The problem appears with multi-dose vials

Im involved in some research and processes where weve actually taken, lets say, a peptide like that